Repligen Corporation (RGEN)

NMS – Real Time Price. Currency in USD

147.01

+1.78 (1.23%)

At close: Jun 26, 2026, 4:00 PM EDT

146.99

-0.02 (-0.01%)

After-hours: Jun 26, 2026, 7:53 PM EDT

04.06.2026

Repligen (RGEN) Down 3.2% Since Last Earnings Report: Can It Rebound?

Repligen (RGEN) reported earnings 30 days ago. What's next for the stock?

04.06.2026

Alger SICAV - Alger Small Cap Focus Fund Q1 2026 Portfolio Update

During the first quarter of 2026, the largest portfolio sector weightings were Health Care and Industrials. RBC Bearings Incorporated, Cognex Corporation and Nebius Group were among the top contributors to performance. Repligen Corporation, Agilysys, Inc., and GeneDx Holdings Corp. were among the top detractors from performance.

03.06.2026

Repligen Corporation (RGEN) Presents at 46th Annual William Blair Growth Stock Conference Transcript

31.05.2026

Repligen Has A Cleaner Recovery Angle, But With High Valuation

22.05.2026

Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference

WALTHAM, Mass., May 22, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in the William Blair 46th Annual Growth Stock Conference in Chicago, IL. Olivier Loeillot, President and Chief Executive Officer, will present a company overview on June 3rd at 10:40 a.m. CT.

20.05.2026

Repligen Announces Publication of the Company's 2025 Corporate Sustainability Report

WALTHAM, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital publication of its 2025 Corporate Sustainability Report and related reporting framework disclosures. Themed “Driving Sustainable Growth Together”, this report communicates the company's progress in advancing our sustainability strategy across six key impact areas: Products & Packaging, Operations, Talent, Supply Chain, Communities, and Pathways to Success. Also included in the 2025 Sustainability Report are detailed disclosures aligned with the United Nations Sustainable Development Goals (UN SDGs) and three key reporting frameworks: the Global Reporting Initiative (GRI) Standards, Sustainability Accounting Standards Board (SASB) Standards and the Task Force on Climate-related Financial Disclosures (TCFD), now part of the IFRS Sustainability Alliance.

12.05.2026

Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Videos

No Data

There is no data to display

Press releases

20.05.2026

Repligen Announces Publication of the Company's 2025 Corporate Sustainability Report

05.05.2026

Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance

WALTHAM, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its first quarter of 2026, covering the three-month period ended March 31, 2026. The Company is also providing updated financial guidance for the full year 2026.

17.04.2026

Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network

WALTHAM, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the grand opening of its new Repligen Training & Innovation Center (“RTIC”) at its OPUS® Pre-packed Chromatography Columns manufacturing facility in Breda, the Netherlands. The RTIC buildout, which features product exhibits and purpose-built demonstration areas, was designed to provide customers with pre- and post-sales support, and a hands-on experience with Repligen's innovative bioprocessing solutions.

24.02.2026

Repligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance

WALTHAM, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its fourth quarter of 2025, covering the three- and twelve- month periods ended December 31, 2025. The Company is also providing financial guidance for the full year 2026.

Repligen Corporation (RGEN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Repligen Corporation (RGEN)

Repligen (RGEN) Down 3.2% Since Last Earnings Report: Can It Rebound?

Alger SICAV - Alger Small Cap Focus Fund Q1 2026 Portfolio Update

Repligen Corporation (RGEN) Presents at 46th Annual William Blair Growth Stock Conference Transcript

Repligen Has A Cleaner Recovery Angle, But With High Valuation

Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference

Repligen Announces Publication of the Company's 2025 Corporate Sustainability Report

Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Videos

No Data

Press releases

Repligen Announces Publication of the Company's 2025 Corporate Sustainability Report

Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance

Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network

Repligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance

Repligen (RGEN) Down 3.2% Since Last Earnings Report: Can It Rebound?

Alger SICAV - Alger Small Cap Focus Fund Q1 2026 Portfolio Update

Repligen Corporation (RGEN) Presents at 46th Annual William Blair Growth Stock Conference Transcript

Repligen Has A Cleaner Recovery Angle, But With High Valuation

Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference

Repligen Announces Publication of the Company's 2025 Corporate Sustainability Report

Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Videos

No Data

Press releases

Repligen Announces Publication of the Company's 2025 Corporate Sustainability Report

Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance

Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network

Repligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance

Search stocks

Repligen Corporation (RGEN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Repligen Corporation (RGEN)

Repligen (RGEN) Down 3.2% Since Last Earnings Report: Can It Rebound?

Alger SICAV - Alger Small Cap Focus Fund Q1 2026 Portfolio Update

Repligen Corporation (RGEN) Presents at 46th Annual William Blair Growth Stock Conference Transcript

Repligen Has A Cleaner Recovery Angle, But With High Valuation

Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference

Repligen Announces Publication of the Company's 2025 Corporate Sustainability Report

Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Videos

No Data

Press releases

Repligen Announces Publication of the Company's 2025 Corporate Sustainability Report

Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance

Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network

Repligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance

Repligen (RGEN) Down 3.2% Since Last Earnings Report: Can It Rebound?

Alger SICAV - Alger Small Cap Focus Fund Q1 2026 Portfolio Update

Repligen Corporation (RGEN) Presents at 46th Annual William Blair Growth Stock Conference Transcript

Repligen Has A Cleaner Recovery Angle, But With High Valuation

Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference

Repligen Announces Publication of the Company's 2025 Corporate Sustainability Report

Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Videos

No Data

Press releases

Repligen Announces Publication of the Company's 2025 Corporate Sustainability Report

Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance

Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network

Repligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance